Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 4, 2025
- Accession no.
- 0001106578-25-000026
- Filed
- Nov 4, 2025
- Trade date
- Oct 31-Nov 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.55M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Oct 31, 2025 | Common Stock | SSaleDisposed | −1,000 | $447.83F2 | −$447,830 | 3,130 | Direct | |
| Oct 31, 2025 | Common Stock | SSaleDisposed | −537 | $449.84 | −$241,564.08 | 2,593 | Direct | |
| Oct 31, 2025 | Common Stock | SSaleDisposed | −2,463 | $451.49F3 | −$1,112,019.87 | 130 | Direct | |
| Nov 3, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −1,140 | $433.78F4 | −$494,509.2 | 2,990 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −360 | $434.33F5 | −$156,358.8 | 2,630 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −1,000 | $438.62F6 | −$438,620 | 1,630 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −500 | $441.39 | −$220,695 | 1,130 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −1,000 | $443.01 | −$443,010 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 134,000 | Direct | |
| Nov 3, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 130,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $447.615 to $448.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $451.18 to $451.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $433.245 to $434.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $434.295 to $434.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $438.51 to $438.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.